Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hypersensitivity Reaction

Free Subscription Articles published in J Dermatol Retrieve available abstracts of 60 articles: HTML format

Single Articles

October 2025
1. PENG G, Abudouwanli A, Sun Q, Tan Y, et al
   Role of Antimicrobial Peptides in the Pathogenesis of Atopic Dermatitis.
   J Dermatol. 2025 Oct 8. doi: 10.1111/1346-8138.17975.
   PubMed     Abstract available
   
   
   September 2025
2. DEKIO I, Katsuta M, Ishiuji Y, Nobeyama Y, et al
   Discontinuation Reasons and Drug Survival of Dupilumab in Real-World Adult Atopic Dermatitis Patients in Three Healthcare Facilities in Tokyo and Yokohama (2018-2023).
   J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17927.
   PubMed     Abstract available
   
   
   August 2025
3. ABE M, Igarashi A, Kitajima H, Toyama H, et al
   Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis.
   J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17915.
   PubMed     Abstract available
   
   
   
4. MATSUO M, Takagi H, Iwata H
   A Case of Atopic Dermatitis Accompanied by Prurigo Nodularis Developed Eosinophilic Pneumonia on Dupilumab Therapy.
   J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17892.
   PubMed    
   
   
   July 2025
5. SASAKI W, Saito R, Suzuki K, Watanabe D, et al
   Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.
   J Dermatol. 2025 Jul 23. doi: 10.1111/1346-8138.17877.
   PubMed     Abstract available
   
   
   
6. TAKAMURA S, Sugai S, Fukuda T
   Long-Term Clinical Courses and Stratified Management of Dupilumab-Associated Inflammatory Arthritis in Atopic Dermatitis: Two Japanese Cases With Over 200 Weeks of Follow-Up and Musculoskeletal Ultrasound Assessment.
   J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17873.
   PubMed    
   
   
   
7. CHEN HC, Chen YC, Chuang MH, Chien WC, et al
   Increased Risk of Chronic Kidney Disease in Atopic Dermatitis: A Nationwide, Population-Based Cohort Analysis.
   J Dermatol. 2025 Jul 10. doi: 10.1111/1346-8138.17841.
   PubMed     Abstract available
   
   
   June 2025
8. YUNOKI M, Kondo S, Otsuka M, Tokura Y, et al
   A Case of Anaphylaxis to Persulfate Salts Contained in Hair Bleaching Powder, Showing Exclusive Immediate-Type but not Delayed-Type Allergy.
   J Dermatol. 2025 Jun 27. doi: 10.1111/1346-8138.17837.
   PubMed    
   
   
   
9. ABE M, Igarashi A, Kitajima H, Toyama H, et al
   Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment for Atopic Dermatitis-Induced Rash on the Face and Neck: Efficacy at Reducing Local Side Effects of Topical Steroid and Tacrolimus Ointment.
   J Dermatol. 2025 Jun 26. doi: 10.1111/1346-8138.17817.
   PubMed     Abstract available
   
   
   
10. KAWAKAMI D, Hagihara E, Hata T, Hasegawa J, et al
    Coconut Anaphylaxis Induced by Occupational Sensitization to Cosmetics via the Skin in a Spa Therapist.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17820.
    PubMed    
    
    
    
11. TONE Y, Matsui M, Park A, Otani S, et al
    A Case of Stevens-Johnson Syndrome Induced by Selpercatinib.
    J Dermatol. 2025;52:1066-1069.
    PubMed     Abstract available
    
    
    
12. SUEKI H, Sugiyama S, Aoyama Y, Yamamoto T, et al
    Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.
    J Dermatol. 2025;52:1015-1030.
    PubMed     Abstract available
    
    
    May 2025
13. AKAI N, Hashimoto T, Okuno S, Takai S, et al
    Apalutamide-Induced Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms Involving Reactivation of Human Herpesvirus-6 and Cytomegalovirus: A Case Report.
    J Dermatol. 2025 May 19. doi: 10.1111/1346-8138.17787.
    PubMed    
    
    
    
14. LI C, Dai M, Gu Q, Lu K, et al
    Incidence of the Stevens-Johnson syndrome spectrum and its patterns in urban China.
    J Dermatol. 2025;52:897-906.
    PubMed     Abstract available
    
    
    
15. TANEMURA A, Ma Y, Sakaki-Yumoto M, Hiro S, et al
    Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database.
    J Dermatol. 2025;52:831-840.
    PubMed     Abstract available
    
    
    April 2025
16. SHEN MH, An HY, Shih CL
    Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor Analysis.
    J Dermatol. 2025 Apr 12. doi: 10.1111/1346-8138.17738.
    PubMed     Abstract available
    
    
    
17. YAMAMURA S, Myangat TM, Sawamura S, Shimada S, et al
    Serum circulating S100A7 and S100A15 DNA copies are elevated in patients with psoriasis and atopic dermatitis.
    J Dermatol. 2025 Apr 1. doi: 10.1111/1346-8138.17727.
    PubMed     Abstract available
    
    
    March 2025
18. CHO YT, Chou HI, Chan TC, Chen YC, et al
    Disease burden and treatment preference for moderate-to-severe atopic dermatitis in Taiwan: A discrete-choice experiment.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17721.
    PubMed     Abstract available
    
    
    
19. MORI Y, Okamoto-Kawai N, Inuo C, Matsumoto S, et al
    Usefulness of gibberellin-regulated protein specific IgE measurement in patients with systemic symptoms of apple allergy with exercise.
    J Dermatol. 2025 Mar 12. doi: 10.1111/1346-8138.17691.
    PubMed     Abstract available
    
    
    
20. TAKEUCHI S, Zeze N, Imayama S, Nakahara T, et al
    Case of allergic contact dermatitis caused by polyurethane elastic cannula.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17687.
    PubMed    
    
    
    
21. KUBO A
    History and prospects of Nagashima-type palmoplantar keratosis, the most common palmoplantar keratoderma in east Asian populations.
    J Dermatol. 2025;52:408-415.
    PubMed     Abstract available
    
    
    
22. KIM MH
    Epidemiological insights into chronic urticaria, vitiligo, alopecia areata, and herpes zoster following COVID-19 infection: A nationwide population-based study.
    J Dermatol. 2025;52:499-504.
    PubMed     Abstract available
    
    
    February 2025
23. HAMASAKI M, Sakai T, Hatano Y
    Cochineal allergy confirmed by specific IgE testing: Review of diagnostic sensitivity.
    J Dermatol. 2025 Feb 20. doi: 10.1111/1346-8138.17674.
    PubMed    
    
    
    
24. KAWAMOTO M, Sakai T, Uchimura K, Shono T, et al
    Anaphylaxis triggered by dog contact and exhaustion in a dog-allergic patient with atopic dermatitis.
    J Dermatol. 2025 Feb 17. doi: 10.1111/1346-8138.17676.
    PubMed    
    
    
    
25. VAN BUCHEM-POST NF, Ouwerkerk W, Stalman EW, van Dam KPJ, et al
    Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
    J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17664.
    PubMed     Abstract available
    
    
    
26. MA Y, Chachin M, Hirose T, Nakamura K, et al
    Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17643.
    PubMed     Abstract available
    
    
    
27. MIZUKAWA Y, Hama N, Niihara H, Miyagawa F, et al
    Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
    J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17609.
    PubMed     Abstract available
    
    
    
28. YAMAMOTO T
    Erythroderma in the elderly.
    J Dermatol. 2025;52:221-227.
    PubMed     Abstract available
    
    
    
29. MORIOKE S, Moriwaki M, Tanaka A, Hide M, et al
    A case of chronic spontaneous urticaria with wheals lasting for more than a week.
    J Dermatol. 2025;52:344-347.
    PubMed     Abstract available
    
    
    
30. HIDE M, Kishimoto M, Kotera I, Oh A, et al
    Analysis of disease burden in patients with hereditary angioedema from Japan by patient-reported outcomes.
    J Dermatol. 2025;52:256-269.
    PubMed     Abstract available
    
    
    January 2025
31. SUGIYAMA A, Yano-Takamori A, Kojima K, Nishie H, et al
    Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events.
    J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17626.
    PubMed     Abstract available
    
    
    
32. TRUPIANO N, Young K, Echuri H, Maghfour J, et al
    Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis.
    J Dermatol. 2025 Jan 15. doi: 10.1111/1346-8138.17622.
    PubMed     Abstract available
    
    
    
33. CHIBA K, Shibata Y, Nobeyama Y, Ohko K, et al
    A case of allergic urticaria induced by green tea and matcha.
    J Dermatol. 2025 Jan 8. doi: 10.1111/1346-8138.17624.
    PubMed    
    
    
    December 2024
34. SAEKI H, Ohya Y, Arakawa H, Ichiyama S, et al
    English version of clinical practice guidelines for the management of atopic dermatitis 2024.
    J Dermatol. 2024 Dec 20. doi: 10.1111/1346-8138.17544.
    PubMed     Abstract available
    
    
    
35. KAMADA H, Arakawa N, Kato M, Tanji T, et al
    Nemolizumab-induced exacerbation of atopic dermatitis.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17589.
    PubMed    
    
    
    
36. IGARASHI A, Tsuji G, Murata R, Fukasawa S, et al
    A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17587.
    PubMed     Abstract available
    
    
    September 2024
37. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
    Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17451.
    PubMed     Abstract available
    
    
    
38. SATO T, Nakazono M, Ohyachi K, Okaniwa A, et al
    HPV 51-associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17454.
    PubMed    
    
    
    
39. KUZUMI A, Yoshizaki A, Matsuda K, Nagai K, et al
    Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome.
    J Dermatol. 2024;51:1240-1244.
    PubMed     Abstract available
    
    
    
40. ENDO M, Yamamoto T
    Sarcoid reaction in lymph node metastasis of genital Paget disease.
    J Dermatol. 2024;51:e302-e303.
    PubMed    
    
    
    
41. KAMIGA M, Hayashi S, Ikegami T, Tokoro S, et al
    Hereditary angioedema with a normal C1 inhibitor in Japanese man.
    J Dermatol. 2024;51:e298-e299.
    PubMed    
    
    
    
42. MASUYUKI R, Sato E, Imafuku S
    A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody.
    J Dermatol. 2024;51:1252-1255.
    PubMed     Abstract available
    
    
    August 2024
43. MATSUMOTO C, Kawakami Y, Ishibashi O, Sagara I, et al
    A clinical case of anaphylaxis after eating oatmeal contaminated with booklice (Liposcelis bostrychophila).
    J Dermatol. 2024 Aug 10. doi: 10.1111/1346-8138.17419.
    PubMed     Abstract available
    
    
    July 2024
44. MINAMI Y, Kanzaki M, Egusa C, Ito T, et al
    A case of anaphylaxis after ingestion of Enokitake (Flammulina velutipes): Detection of the causative antigens.
    J Dermatol. 2024 Jul 12. doi: 10.1111/1346-8138.17383.
    PubMed    
    
    
    June 2024
45. HIOKI C, Oda Y, Moriwaki S, Fukunaga A, et al
    Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases.
    J Dermatol. 2024;51:873-877.
    PubMed     Abstract available
    
    
    May 2024
46. YOSHIDA K, Numata T, Sugisaki R, Ito T, et al
    Orofacial granulomatosis associated with indium allergy and apical periodontitis.
    J Dermatol. 2024 May 31. doi: 10.1111/1346-8138.17286.
    PubMed    
    
    
    
47. TAIRA H, Ito Y, Yamamoto T, Koyama A, et al
    Elevated serum vasohibin-1 levels in atopic dermatitis: Implications for disease chronicity.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17259.
    PubMed     Abstract available
    
    
    April 2024
48. TANAKA A, Yuasa A, Kamei K, Nagano M, et al
    Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan.
    J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17234.
    PubMed     Abstract available
    
    
    
49. FUJIOKA K, Kita M, Iwata M, Moriue T, et al
    Multiple cutaneous focal mucinosis in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17213.
    PubMed    
    
    
    
50. SUGIURA R, Hashimoto T, Okuno S, Satoh T, et al
    Expression of phosphorylated-Janus kinase 1 and IL-4Ralpha by dermal basophils and epidermal keratinocytes in atopic dermatitis-associated prurigo nodules: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17229.
    PubMed    
    
    
    
51. BABA A, Yamada K, Kanekura T
    Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17188.
    PubMed     Abstract available
    
    
    
52. LIU Q, Su H, Hong C, Han J, et al
    Toxic epidermal necrolysis complicated with primary cutaneous aspergillosis: A report of four cases.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17226.
    PubMed     Abstract available
    
    
    
53. HANAMI Y, Yamamoto T
    Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 8. doi: 10.1111/1346-8138.17199.
    PubMed    
    
    
    
54. PAN X, Dong Z
    Yellow urticaria following plasma transfusion.
    J Dermatol. 2024;51:e108-e109.
    PubMed    
    
    
    
55. CHATPROEDPRAI S, Tiasiri N, Chantawarangkul K, Wananukul S, et al
    Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
    J Dermatol. 2024;51:509-517.
    PubMed     Abstract available
    
    
    March 2024
56. HEMMI A, Okamura K, Nikaido M, Saito T, et al
    Post-COVID-19 vaccination diffuse cutaneous sarcoidosis.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17194.
    PubMed    
    
    
    
57. UCHIYAMA A, Kosaka K, Ishikawa M, Inoue Y, et al
    Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17173.
    PubMed     Abstract available
    
    
    February 2024
58. HASHIZUME H, Ishikawa Y, Hata A
    Increased Demodex mites after dupilumab therapy in facial skin: A case report.
    J Dermatol. 2024 Feb 29. doi: 10.1111/1346-8138.17150.
    PubMed    
    
    
    
59. KOJIMA R, Miyake K, Shinohara R, Kushima M, et al
    Association between filaggrin gene mutations and the clinical features of molluscum contagiosum: The Yamanashi Adjunct Study of the Japan Environment and Children's Study.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17157.
    PubMed     Abstract available
    
    
    December 2023
60. NAKAIZUMI H, Kambe N, Irie H, Kaku Y, et al
    Neutrophilic epitheliotropism, proposed as an auto-inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases.
    J Dermatol. 2023 Dec 6. doi: 10.1111/1346-8138.17067.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.